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Table 1: Eligibility criteria for systematic review 
Inclusion criteria Exclusion criteria 
Participants:  
All adults with type 1 or type 2 diabetes 
mellitus (DM) 
 
Children and adolescents (age below 18 
years) 
Pregnant females 
Gestational diabetes mellitus 
Maturity onset diabetes of the young 
Latent autoimmune diabetes of adulthood 
No type 1 or type 2 DM 
Exposure:  
Those with obstructive sleep apnea 
(OSA) or chronic intermittent hypoxemia 
(CIH) 
 
Hypoxemia secondary to other respiratory 
disorders 
Chronic obstructive pulmonary disease 
Central sleep apnea 
Heart failure 
Asthma  
Comparator:  
Adults without OSA or CIH 
 
 
Outcomes:  
Diabetic kidney disease (micro- and 
macro-albuminuria and chronic kidney 
disease assessed using glomerular 
filtration rate) 
 
Renal impairment secondary to non-DM 
causes 
Study designs:  
Cross sectional study 
Cohort study  
Case series 
 
Non-human studies 
Single case reports 
Sample size < 10 participants 
Randomised controlled trials 
Intervention studies 
Experimental studies 
Systematic reviews/reviews 
Editorials 
Protocol papers 
Letters 
Guidelines/consensus statements 
Language:  
All languages 
 
  
 
 
 
 
 
 
 
 
 
 
Search strategy:  
 
Table 2: Search terms for MEDLINE, EMBASE and Cochrane Database 
Search terms for diabetic kidney disease 
1. Diabet$.mp. 
2. Respiratory system/ or breathing disorder/ or snoring/ or hypoventilation/ or sleep/ 
or polysomnography/ or sleep apnea syndrome/ or breathing/ or sleep disordered 
breathing/ or sleep disorder/ 
3. Hypoxemia/ or respiratory function disorder/ or anoxia/ or hypoxia/ 
4. Somnolence/ or apnea/ or apnea hypopnea index/ or hypopnea.mp. 
5. 2 or 3 or 4 
6. 1 and 5 
7. Nephropathy.mp. or kidney disease/ 
8. Albuminuria.mp. or proteinuria/ or albuminuria/ 
9. $albuminuria.mp. 
10. Renal failure.mp. 
11. Kidney function/ 
12. Diabetic nephropathy/ or nephropa$.mp. or chronic kidney failure/ 
13. 7 or 8 or 9 or 10 or 11 or 12 
14. 6 and 13 
 
The free text used for OpenGrey database were “obstructive sleep apnea” and “obstructive 
sleep apnoea” 
 
The search terms for Zetoc database included “obstructive sleep apnea and diabetes”, 
“obstructive sleep apnoea and diabetes”, “apnea and diabetes” and “apnoea and diabetes”. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3: Quality assessment form 
Author:                                                        Year:                                     Study ID:                                                         
Reviewer initials: 
 Yes/No/ 
Unclear 
Supporting 
evidence 
Selection bias 
1. Does the study address an appropriate and 
clearly focused question?  
  
2. Does the study recruit consecutive patients?    
3. Are the cases and controls taken from 
comparable populations?  
  
4. Are the exclusion criteria the same for both 
cases and controls?  
  
5. Are the participants representative of the patient 
population? 
  
6. If applicable, is the control group comparable to 
cases (consider suitability, recruitment and 
baseline characteristics)? 
  
7. Is it clear that controls are not cases (in case 
control study)? 
  
Overall Judgement (Weak / Moderate /Strong)   
Respiratory measurement 
1. Did the study use a suitable measurement for 
OSA? (PSG/oximetry measured in standard, 
valid and reliable way) 
  
2. Is the scoring of the respiratory measures based 
on guidelines/consensus guidelines eg. AASM 
guidelines?  
  
3. Is there a clear definition of OSA?    
Overall Judgement (Weak / Moderate / Strong)   
Blinding  
1. Did the study blind the assessor performing the 
sleep analysis? 
  
Overall Judgement (Weak / Moderate / Strong)   
Study methods 
1. Are the attrition rates or missing data clearly 
documented? 
  
2. Did the study document the reasons for drop 
outs or missing data? 
  
3. Is this a retrospective or prospective design?    
Overall Judgement (Weak / Moderate / Strong)   
Analysis  
1. Are all the outcomes reported?   
2. Did the study adjust for confounding variables?   
Overall Judgement (Weak / Moderate /Strong)   
Overall judgement for the study (Weak, Moderate, 
Strong) 
 
Table 4: Criteria used for the diagnosis of obstructive sleep apnea and diabetic kidney disease assessment as reported by the included studies  
Study  Definition of apnea/hypopnea or 
oxygen desaturation (OD)  
OSA diagnosis Min 
recording  
DKD test DKD diagnosis  
Buyukaydin 
20121 
AASM criteria* AHI≥5 events/hr NA 24 hour urine albumin Albuminuria ≥ 30mg/day 
Furukawa 20132  OD ≥3% ODI≥5 events/hr 4 hours Early morning urine 
ACR 
Micro-albuminuria 
≥3.4mg/mmol 
Macro-albuminuria ≥ 34.0 
mg/mmol 
Kosseifi 20103 NA NA NA NA Micro-albuminuria 
Laaban 20094 Apnea =  increased variation in 
suprasternal pressure with no airflow 
for ≥10 seconds; hypopnea = ≥50% 
reduction in airflow with ≥4% 
desaturation for ≥ 10 seconds 
AHI≥5 events/hr NA 24 hour urine albumin Micro-albuminuria ≥ 
30mg/day 
Langrand 20145 NA NA NA NA NA 
Leong 20146  AASM criteria* AHI≥5 events/hr 4 hours eGFR  eGFR <60min/ml/1.73m2 
based on MDRD and CKD-
EPI equations 
Schober 20117 Apnea = 80% reduction in airflow ≥ 
10 seconds; hypopnea = 50-80% 
reduction in airflow with ≥ 4% 
desaturations for ≥ 10 seconds 
AHI≥15 
events/hr 
NA NA NA 
Storgaard 20148 Apnea = 80% reduction in airflow ≥ 
10 seconds; hypopnea = 50-80% 
reduction in airflow with ≥ 4% 
desaturations for ≥ 10 seconds 
AHI≥5 events/hr 4 hours 24 hour urine albumin  Micro-albuminuria 30-300 
mg/day 
Macro-albuminuria > 
300mg/day  
(2 out of 3 samples 
Tahrani 20139 AASM criteria* AHI≥5 events/hr 4 hours eGFR & 
urine ACR 
MDRD eGFR 
<60min/ml/1.73m2 
ACR >3.4 mg/mmol 
Tanaka 200910 OD ≥3% ODI≥5 events/hr NA Creatinine (mg/dl) NA 
Zhang 201411 NA AHI≥5 events/hr NA NA NA 
Zhang 201512 Apnea = 80% reduction in airflow ≥ AHI≥5 events/hr NA  Urine ACR or medical ACR >300mg 
10 seconds; hypopnea = 50-80% 
reduction in airflow with ≥ 4% 
desaturations for ≥ 10 seconds 
history 
OD = oxygen desaturation, min = minimum, OSA = obstructive sleep apnea, hr = hour, NA = not available, DKD = diabetic kidney disease, eGFR = estimated 
glomerular filtration rate, MDRD = Modification of Diet in Renal Disease, CKD-EPI = Chronic Kidney Disease Epidemiology Collaboration, ACR = albumin-
creatinine ratio.*AASM = American Academy of Sleep Medicine criteria: apnea = complete cessation of airflow for ≥10 seconds; hypopnea = ≥30% reduction in 
airflow ≥4% drop in oxygen desaturation for ≥10 seconds.  
Table 5: Summary of the results for diabetic kidney disease 
 Diabetic kidney disease 
OSA  
(based on AHI) 
10 studies (n=2927)1, 3-9, 11, 12  
Adjusted: (+) 3 studies6, 9, 11; (-) 0 studies 
  
Unadjusted : (+) 1 studies4; (-)  6 studies1, 3, 5, 7, 8, 12 
Pooled OR (7 studies1, 4, 6-9, 12 – see Figure  1, supplementary 
materials) 
1.59. 95% CI: 1.16 to 2.18 I2= 26.8% 
 
OSA  
(based on ODI) 
2 studies (n=1317)2, 10  
Adjusted: (+) 2 study2, 13; (-) 0 studies 
Pooled OR (2 studies2, 10 – see Figure 3, supplementary materials) 
2.00. 95% CI: 1.36 to 2.94 I2= 0.0% 
 
Pooled OR (4 studies2, 9-11, combined AHI & ODI as OSA diagnosis – 
see Figure 2, main manuscript) 
1.73, 95% CI: 1.13 to 2.64, I2= 69.3% 
 
Unadjusted: No data 
 
%TST<90 2 studies (n=158)5, 6 
Adjusted: (+) 1 study6; (-) 0 study 
 
Unadjusted: (+) 1 study5; (-) 0 study 
 
Mean O2 2 studies (n=158)5, 6 
Adjusted: (+) 0 study; (-) 1 study6 
 
Unadjusted: (+) 1 study5; (-) 0 study 
 
Minimum O2 3 studies (n=491)3, 6, 9 
Adjusted: (+) 0 study; (-) 2 studies6, 9 
 
Unadjusted: (+) 1 study3; (-) 0 study  
 
(+): reported significant association; (-): reported no significant associations; shaded cells indicate 
that no study reported data for the exposure-outcome combination. DR = diabetic retinopathy; OSA 
= obstructive sleep apnoea; AHI = apnoea-hypopnoea index; ODI = oxygen desaturation index; 
%TST<90 = percentage time spent under 90% oxygen saturation; O2 = oxygen saturation, n = total 
number of participants 
 
 
 
 
 
Meta-analysis 
Three studies3, 5, 11 did not report on their results therefore a meta-analysis was 
carried out for seven studies1, 4, 6-9, 12 which reported unadjusted ORs on the 
association between OSA (defined using AHI) and DKD. The pooled estimates 
showed significant association (pooled OR 1.59, 95% CI: 1.16 to 2.18, I2=26.8%, 
Figure 1) using random effects analysis. The funnel plot of these studies1, 4, 6-9, 12 
suggest an imbalance of small studies with positive results.  
 
 
 
Figure 1: Forest plot of the association between obstuctive sleep apnea and diabetic 
kidney disease using results from studies which reported unadjusted odds ratios and 
95% confidence intervals. Random effects analysis performed using Stata 13. Fixed 
effects model yielded similar results (pooled OR 1.60, 95% CI: 1.25 to 2.05, 
I2=26.8%) 
NOTE: Weights are from random effects analysis
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 Figure 2: Funnel plot on studies which reported unadjusted odds ratios.  
 
Figure 3: Forest plot of the association between obstuctive sleep apnea diagonsed 
using ODI and diabetic kidney disease using results from studies which reported 
adjusted odds ratios and 95% confidence intervals.  
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